A single-team experience of limb sparing approach in adults with high-grade malignant fibrous histiocytoma

Oncology Reports

Volumn 14, Issue 4, 2005, Pages 1071-1076

  Issakov, Josephine ^a,b   Kollender, Yehuda ^a,b   Soyfer, Viacheslav ^a,b   Bickels, Jacob ^a,b   Flusser, Gideon ^a,b   Meller, Isaac ^a,b   Merimsky, Ofer ^a,b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Adult; Limb; Limb sparing approach; Malignant fibrous histiocytoma; Radiation therapy; Soft tissue sarcoma; Surgery

Indexed keywords

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; DERMATOFIBROMA; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LIMB; MALE; MIDDLE AGED; PATHOLOGY; RECURRENT DISEASE; RETROSPECTIVE STUDY; SOFT TISSUE TUMOR; TIME; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; EXTREMITIES; FEMALE; HISTIOCYTOMA, BENIGN FIBROUS; HUMANS; MALE; MIDDLE AGED; RADIOTHERAPY, ADJUVANT; RECURRENCE; RETROSPECTIVE STUDIES; SOFT TISSUE NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME;

EID: 33644830801     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.14.4.1071     Document Type: Article

References (19)

1. Enjoji M, Hashimoto H, Tsuneyoshi M and Iwasaki H: Malignant fibrous histiocytoma: a clinicopathologic study of 130 cases. Acta Pathol Jpn 30: 727-741, 1980. (Pubitemid 11163551)
2. Rydholm A and Syk I: Malignant fibrous histiocytoma of soft tissue. Correlation between clinical variables and histologic malignancy grade. Cancer 57: 2323-2324, 1986. (Pubitemid 16118970)
3. Bertoni F, Capanna R, Biagini R, Bacchini P, Guerra A, Ruggieri P, Present D and Campanacci M: Malignant fibrous histiocytoma of soft tissue: an analysis of 78 cases located and deeply seated in the extremities. Cancer 56: 356-367, 1985. (Pubitemid 15031660)
4. Rosenberg SA, Tepper J, Glatstein E, Costa J, Baker A, Brennan M, DeMoss EV, Seipp C, Sindelar WF, Sugarbaker P and Wesley R: The treatment of soft tissue sarcoma of the extremities: prospective randomized evaluations of i) limb-sparing surgery plus radiation therapy compared with amputation and ii) the role of adjuvant chemotherapy. Ann Surg 196: 305-315, 1982. (Pubitemid 12052461)
5. Merimsky O, Kollender Y, Inbar M, Lev-Chelouche D, Gutman M, Issakov J, Mazeh D, Shabat S, Bickels J and Meller I: Is forequarter amputation justified for palliation of intractable cancer symptoms? Oncology 60: 55-59, 2001. (Pubitemid 32041432)
6. Janice N, Cormier JN, Huang X, Xing Y, Thall PF, Wang X, Benjamin RS, Pollock RE, Antonescu CR, Maki RG, Brennan MF and Pisters PWT: Cohort analysis of patients with localized, high-risk, extremity soft tissue sarcoma treated at two cancer centers: chemotherapy-associated outcomes. J Clin Oncol 22: 4567-4574, 2004. (Pubitemid 41185124)
7. Gutman M, Inbar M, Lev-Shlush D, Abu-Abid S, Mozes M, Chaitchik S, Meller I, et al: High dose tumor necrosis factor-α and melphalan administered via isolated limb perfusion for advanced limb soft tissue sarcoma results in a >90% response rate and limb preservation. Cancer 79: 1129-1137, 1997. (Pubitemid 27118210)
8. Eggermont AMM, Schraffordt Koops H, Lienard D, Kroon BBR, van Geel AN, Hoekstra HJ and Lejeune FJ: Isolated limb perfusion with high-dose tumor necrosis factor α in combination with interferon-γ and melphalan for non-resectable extremity soft tissue sarcomas: a multicentric trial. J Clin Oncol 14: 2653-2665, 1996. (Pubitemid 26329649)
9. Enzinger FM: Malignant fibrous histiocytoma 20 years after Stout. Am J Surg Pathol 10 (Suppl 1): 43-53, 1986.
10. Weiss SW and Enzinger FM: Malignant fibrous histiocytoma: an analysis of 200 cases. Cancer 41: 2250-2266, 1978. (Pubitemid 8370196)
11. Fletcher CD, Unni KK and Mertens F: World Health Organization Classification of Tumours. Pathology and genetics of tumours of soft tissue and bone. IARC Press, Lyon, 2002.
12. Fletcher CD: Pleomorphic malignant fibrous histiocytoma: fact or fiction? A critical reappraisal based on 159 tumors diagnosed as pleomorphic sarcoma. Am J Surg Pathol 16: 213-228, 1992.
13. Fletcher CD, Gustafson P, Rydholm A, Willen H and Akerman M: Clinicopathologic re-evaluation of 100 malignant fibrous histiocytomas: prognostic relevance of subclassification. J Clin Oncol 19: 3045-3050, 2001. (Pubitemid 32565442)
14. Hollowood K and Fletcher CD: Malignant fibrous histiocytoma: morphologic pattern or pathologic entity? Semin Diagn Pathol 12: 210-220, 1995.
15. Hogendoorn PC, Collin F, Daugaard S, Dei Tos AP, Fisher C, Schneider U and Sciot R: Pathology and biology subcommittee of the EORTC soft tissue and bone sarcoma group. Changing concepts in the pathological basis of soft tissue and bone sarcoma treatment. Eur J Cancer 40: 1644-1654, 2004. (Pubitemid 38902898)
16. Le Doussal V, Coindre JM, Leroux A, Hacene K, Terrier P, Bui NB, Bonichon F, Collin F, Mandard AM and Contesso G: Prognostic factors for patients with localized primary malignant fibrous histiocytoma: a multicenter study of 216 patients with multivariate analysis. Cancer 77: 1823-1830, 1996. (Pubitemid 26125182)
17. Zagars GK, Mullen JR and Pollack A: Malignant fibrous histiocytoma: outcome and prognostic factors following conservation surgery and radiotherapy. Int J Radiat Oncol Biol Phys 34: 983-994, 1996. (Pubitemid 26105436)
18. Salo JC, Lewis JJ, Woodruff JM, Leung DH and Brennan MF: Malignant fibrous histiocytoma of the extremity. Cancer 85: 1765-1772, 1999. (Pubitemid 29169678)
19. Engellau J, Anderson H, Rydholm A, Bauer HC, Hall KS, Gustafson P, Akerman M, Meis-Kindblom J, Alvegard TA, Nilbert M and the Scandinavian Sarcoma Group: Time dependence of prognostic factors for patients with soft tissue sarcoma: a Scandinavian Sarcoma Group Study of 338 malignant fibrous histiocytomas. Cancer 100: 2233-9223, 2004.